Druggable Targets of Squamous Cell Lung Cancer

Tuberculosis and Respiratory Diseases

article

Cheol Hyeon Kim¹ 

[1] Division of Pulmonology, Department of Internal Medicine, Korea Cancer Center Hospital

关键词: Carcinoma;    Squamous Cell;    Lung Neoplasms;   

DOI  :  10.4046/trd.2013.75.6.231

学科分类：医学（综合）

来源: The Korean Academy of Tuberculosis and Respiratory Diseases

【 摘 要 】

Knowledge of molecular pathogenesis of non-small cell lung cancer has increased remarkably and changed the principles of treatment, especially during the past decade. These advancements have been limited mainly to adenocarcinoma of the lung. Recently, genetic alterations in squamous cell lung cancer (SQCLC) have been detailed and positive results of clinical trials using agents targeting these changes have indicated the potential for improved treatment outcomes for SQCLC.

【 授权许可】

CC BY-NC